跳至主要内容
临床试验/NCT04733053
NCT04733053已完成不适用

The POWER Study: Effects of a Physiotherapist-delivered Dietary Weight Loss Program in Addition to Exercise in People with Knee Osteoarthritis Who Have Overweight or Obesity - a Randomised Controlled Trial

University of Melbourne2 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2021年10月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
88
试验地点
2
主要终点
Body weight

研究概览

简要总结

The aim of this randomized controlled trial is to evaluate the effects of a physiotherapist-delivered dietary weight loss program on clinical outcomes among people with knee osteoarthritis (OA) who have overweight or obesity. The primary hypothesis is that a physiotherapist-delivered dietary weight loss plus exercise program will be more effective in achieving weight loss than a physiotherapist-delivered exercise program alone. Approximately 6-9 physiotherapists in Melbourne, Australia will be recruited and trained in weight management for OA patients, as well as trained in how to deliver the specific study interventions. The same therapists will deliver the intervention in both arms of the trial. 88 participants with knee OA will be recruited from the community and randomized into one of the two arms a) diet plus exercise intervention or b) exercise intervention alone. Participants in both groups will be asked to attend 6 consultations with the physiotherapist over 6 months. Questionnaire and laboratory-based outcome measures will be completed by participants at baseline and at the end of the 6 month intervention period. A biostatistician will analyse blinded, de-identified data.

详细描述

Clinical guidelines for the management of knee OA recommend exercise as a core treatment for all patients as well as losing weight for those patients who also have overweight/obesity. However, health care systems are frequently under strain often experiencing limited numbers of, and access to, clinicians with specialist weight loss and health behavior change skills. New models of care for OA are needed that support expanded practice roles for clinicians. Physiotherapists are key providers of exercise therapy for knee OA but the effectiveness of physiotherapists to deliver a dietary weight loss program for patients with knee OA is not known.

This study is a randomized controlled trial for which the aim is to evaluate the effects of a physiotherapist-delivered dietary weight loss program in addition to exercise, on weight loss and other clinical outcomes among people with knee OA who have overweight or obesity. The research question is: Is a 6-month physiotherapist-delivered dietary weight loss plus exercise program more effective for improving clinical outcomes than a physiotherapist-delivered exercise program alone in people with knee OA who have overweight or obesity?

Clinical practice guidelines for knee OA recommend patients who have overweight or obesity should lose at least 5-7.5% of body weight. Therefore the study is powered to detect a conservative between-group difference in weight loss of 5% of body weight assuming no change in weight in the control group (exercise only) based on previous research.

A total of 88 participants with chronic knee pain and a clinical diagnosis of knee OA will be recruited from the community. Participants will be enrolled into the study following informed consent and completion of baseline questionnaires and laboratory-based measures. Each participant will be randomly allocated to receive a: a) diet plus exercise program or; b) exercise program alone, over 6 months.

The randomization schedule will be computer generated and prepared by the biostatistician (permuted block sizes 6 to 12) stratified by physiotherapist and sex of participant. The schedule will be stored on a password-protected website maintained by a researcher not involved in either participant recruitment or administration of outcome measures. Group allocation will be revealed to the physiotherapists and the participants by this same researcher following randomisation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

盲法说明

The components of each treatment arm will be disclosed to participants as we wish to test the interventions under real world conditions whereby consumers are fully informed about the nature of the components before choosing whether or not they wish to participate. The research staff collecting non-self-reported outcome measures (including the primary outcome) will be blinded to group allocation. The staff member collecting laboratory measures at 6 months will be different to the staff member who collects the baseline data. It is not possible to blind physiotherapists as they are providing interventions to both trial arms (in order to ensure physiotherapist-related factors such as personality, clinical practice experience etc are similar across groups and cannot confound results). The person performing the statistical analyses will be blinded.

入排标准

年龄范围
45 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Meet the National Institute for Health and Care Excellence [47] clinical criteria for OA: age≥45 years; activity-related knee joint pain; morning knee stiffness ≤ 30 mins
  • report history of knee pain ≥ 3 months
  • report knee pain on most days of the past month
  • report a minimum knee pain score of 4 on an 11-point numeric rating scale during walking over the previous week
  • body mass index (BMI) >27 kg/m2
  • those using hypertensive medication must be willing to have their blood pressure checked (this can be self-monitoring, at a pharmacist or at a GP) if they feel light-headed or dizzy at any point during the study
  • able to give informed consent and to participate fully in the interventions and assessment procedures

排除标准

  • weight >150 kgs (due to the added complexities of additional nutritional requirements for individuals above this weight)
  • inability to speak English
  • on waiting list for/planning knee/hip surgery or bariatric surgery in next 6 months
  • arthroplasty on affected knee
  • recent knee surgery on affected knee (past 6 months);
  • self-reported inflammatory arthritis (e.g. rheumatoid arthritis)
  • weight loss of > 2 kg over the previous 3 months
  • already actively trying to lose weight by any of the following mechanisms:using meal replacements for weight loss; being a member of a slimming club (e.g. weight watchers); receiving support from another health care professional for weight loss; using any drugs prescribed to aid in weight loss; using structured meal programs for weight loss such as 'Lite n' Easy'
  • unwilling to continue current dietary patterns if randomized to exercise only group
  • unable to undertake ketogenic VLCD for medical reasons including self-reported: diagnosis of Type 1 diabetes;Type 2 diabetes requiring insulin or other medication apart from metformin; Warfarin use; stroke or cardiac event in previous 6 months; unstable cardiovascular conditions; fluid intake restrictions; renal (kidney) problems (unless clearance is obtained from a general practitioner (GP), including GP confirmation that estimated glomerular filtration rate >30 mL/min/1.73m2); any neurological condition affecting lower limbs; vegan dietary requirements due to complexity of delivering a nutritionally complete diet within the ketogenic diet regime

结局指标

主要结局

Body weight

时间窗: Change between baseline and 6 months post randomization

Measured using calibrated digital laboratory platform scales (TCS-2 series) to 2 decimal places, the percentage of body weight change (baseline-follow up/baseline x100%) will be calculated as the primary outcome

次要结局

  • Global overall improvement in knee problems(6 months post randomization)
  • Waist circumference(Change between baseline and 6 months post randomization)
  • Severity of knee pain during walking(Change between baseline and 6 months post randomization)
  • Quality of life (AQoL-6D)(Change between baseline and 6 months post randomization)
  • Physical Activity scale for the elderly (PASE)(Change between baseline and 6 months post randomization)
  • Quadriceps muscle strength(Change between baseline and 6 months post randomization)
  • Weight Self-Stigma Questionnaire (WSSQ)(Change between baseline and 6 months post randomization)
  • Waist to hip ratio(Change between baseline and 6 months post randomization)
  • 40 m fast paced walk test(Change between baseline and 6 months post randomization)
  • Arthritis self-efficacy scale(Change between baseline and 6 months post randomization)
  • Body mass index (BMI)(Change between baseline and 6 months post randomization)
  • 30 sec chair stand test(Change between baseline and 6 months post randomization)
  • Stair climb test(Change between baseline and 6 months post randomization)
  • Intermittent and constant osteoarthritis pain measure (iCOAP)(Change between baseline and 6 months post randomization)
  • Physical function subscale of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)(Change between baseline and 6 months post randomization)
  • Self-efficacy for eating control(Change between baseline and 6 months post randomization)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验